InvestSMART

Health House International Limited (ASX: HHI) - Announcements

DELISTED - Current share price for HHI : $0.005

ASX company news and announcements for Health House International Limited (HHI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Health House International Limited (HHI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Health House International Limited (HHI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Health House International Limited (HHI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- CPH: HHI Update & Product Registration in South Korea 23 Nov 2022 9:31AM $0.013 $0.005 fallen by 61.54%
- CPH:Scheme Implementation Deed signed to acq Health House 21 Nov 2022 9:33AM $0.013 $0.005 fallen by 61.54%
- ZLD: Partial Receipt and variation of Health House loan 21 Nov 2022 9:29AM $0.013 $0.005 fallen by 61.54%
- Scheme implementation deed executed 21 Nov 2022 9:27AM $0.013 $0.005 fallen by 61.54%
- Final Director's Interest Notice 16 Nov 2022 12:49PM $0.013 $0.005 fallen by 61.54%
- HHI completes CanPharma sale and Board changes 16 Nov 2022 11:23AM $0.013 $0.005 fallen by 61.54%
- Health House to sell CanPharma 1 Nov 2022 3:05PM $0.013 $0.005 fallen by 61.54%
- AGM Date and Closing Date for Director Nominations 3 Oct 2022 4:51PM $0.013 $0.005 fallen by 61.54%
- Suspension from Official Quotation 3 Oct 2022 9:58AM $0.013 $0.005 fallen by 61.54%
- Reinstatement to Official Quotation 9 Sep 2022 9:19AM $0.012 $0.005 fallen by 58.33%
- Suspension Lifted 9 Sep 2022 9:19AM $0.012 $0.005 fallen by 58.33%
- ZLD: Partial Receipt of Health House Loan 8 Sep 2022 9:23AM $0.012 $0.005 fallen by 58.33%
- Appendix 3G 5 Sep 2022 10:29AM $0.012 $0.005 fallen by 58.33%
- CPH:Update on Health House International Limited transaction 5 Sep 2022 10:11AM $0.012 $0.005 fallen by 58.33%
- Creso Pharma transaction update and Convertibe Note Issue 5 Sep 2022 10:10AM $0.012 $0.005 fallen by 58.33%
- Appendix 4E Preliminary Final Report 1 Sep 2022 9:29AM $0.012 $0.005 fallen by 58.33%
- Request for Extension of Voluntary Suspension 23 Aug 2022 4:34PM $0.012 $0.005 fallen by 58.33%
- CanPharma secures Dronabinol supply for Germany 18 Aug 2022 9:32AM $0.012 $0.005 fallen by 58.33%
- Application for quotation of securities - HHI 11 Aug 2022 2:05PM $0.012 $0.005 fallen by 58.33%
- Release from Escrow 1 Aug 2022 6:12PM $0.012 $0.005 fallen by 58.33%
- June 2022 Quarterly Report 1 Aug 2022 8:59AM $0.012 $0.005 fallen by 58.33%
- Appendix 4C Cash Flow Report 1 Aug 2022 8:52AM $0.012 $0.005 fallen by 58.33%
- HHI - Request for Extension of Voluntary Suspension 29 Jul 2022 7:29PM $0.012 $0.005 fallen by 58.33%
- Creso makes non-binding indicative proposal to acquire HHI 29 Jul 2022 7:23PM $0.012 $0.005 fallen by 58.33%
- Execution of non-binding term sheet to acquire Health House 29 Jul 2022 7:21PM $0.012 $0.005 fallen by 58.33%

51 - 75 of 162 results

Page 3 of 7

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.